Colonic drug-targeting: In vitro release of ibuprofen from capsules coated with poly(ether-ester) azopolymers

International Journal of Pharmaceutics

Volumn 139, Issue 1-2, 1996, Pages 187-195

  Kalala, Willbrord ^a   Kinget, Renaat ^a   Van Den Mooter, Guy ^a   Samyn, Celest ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Azopolymers; Azoreductase; Biodegradeable polymers; Colonic targeting; Ibuprofen

Indexed keywords

AZO REDUCTASE; IBUPROFEN; MACROGOL; POLYESTER; POLYETHER; POLYMER;

ANIMAL EXPERIMENT; ARTICLE; CECUM; DIFFUSION; DRUG CAPSULE; DRUG COATING; DRUG RELEASE; DRUG TARGETING; DRUG TISSUE LEVEL; HYDROPHILICITY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; RAT;

EID: 0030576548     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(96)04605-4     Document Type: Article

References (23)

1. Brondsted, H., Hovgaard, I. and Simonsen, I., Dextran hydrogels for colon-specific drug delivery IV. Comparative release study of hydrocortisone and prednisolone phosphate. STP Pharma Sciences, 5 (1995) 65-69.
2. Friend, D.R., Glycosides in colonic drug delivery. In Friend, D.R. (Ed.), Oral Colon-specific Drug Delivery, CRC Press, London, 1992, pp. 153-187.
3. Gazzaniga, A., Sangali, M.E. and Giordano, M., Oral Chronotopic® drug delivery systems: Achievement of time and/or site specificity. Eur. J. Pharm. Biopharm., 40 (1994) 246-250.
4. Geisslinger, G., Dietzel, K., Loew, D. et al., High perfomance liquid Chromatographic determination of ibuprofen, its metabolites, and enantiomers in biological fluids. J. Chromatogr., 491 (1989) 139-149.
5. Gruber, P., Longer, M.A. and Robinson, J.R., Some biological issues in oral, controlled drug delivery. Adv. Drug Del. Rev., 1 (1987) 1-8.
6. Hardy, J.G., Colonic transit and drug delivery. In Hardy, J.G., David, S.S. and Wilson G.G., (Eds.), Drug Delivery To The Gastrointestinal Tract., Ellis Horwood, Chichester, 1989, pp 75-81.
7. Ikesue, K., Kopeckova, P. and Kopecek, J., Degradation of proteins by enzymes of the gastrointestinal tract. Proc. Int. Symp. Rel. Bioact. Mater., 18 (1991) 580-581.
8. Kopecek, J., Kopeckova, P., Brondsted, H., Rathi, R., Rihova, B., Yeh, P.Y. and Ikesue, K., Polymers for colon-specific drug delivery. J. Controlled Rel., 19 (1992) 121-130.
9. Lee, V.H.L., Changing needs in drug delivery. In: Lee V.H.L. (Ed.), Peptide and protein drug delivery, Marcel and Dekker, New York, 1991, pp 1-56.
10. Mackay, M. and Thomlinson, E., Colonic delivery of therapeutic peptides and proteins. In Bieck, P.R. (Ed.), Colonic Drug Absorption and Metabolism, Marcel and Dekker, New York, 1993, pp 159-176.
11. Marshal, K. and Rudnic, E.M., Tablet dosage forms. In Banker, G.S. and Rhodes, C.T., (Eds.), Modern Pharmaceutics, Marcel Dekker, New York, 1990, pp 355-425.
12. Milojevic, S., Newton, J.M., Cummings, J. et al., Amylose, the new perspective in oral drug delivery to the human large intestine. STP Pharma Sciences, 5 (1995) 77-82.
13. Peeters, R., Studie over de ontwikkeling van een colon-specifieke artsenijvorm, Doctoral Thesis, K.U. Leuven, Belgium, 1990.
14. Peeters, R. and Kinget, R., Film-forming polymers for colonic drug delivery. I. Synthesis and physical and chemical properties of methyl derivatives of Eudragit S. Int. J. Pharm., 94 (1993) 125-134.
15. Quadros, E., Cassidy, J., Hirschberg, Y. et al., Evaluation of a novel colonic delivery device in vivo. STP Pharma Sciences, 5 (1995) 77-82.
16. Röhm Pharma Monographs. Eudragit® RL and RS, Application in the production of pharmaceutical preparations. Röhm Pharma, Darmstadt, Germany.
17. Rubinstein, A., Radai, R., Ezna, M. and Pathnack, S., In vitro evaluation of calcium pectate: a potential colon-specific drug delivery carrier. Pharm Res., 10 (1993) 258-263.
18. Saffran, M., Field, J.B., Pena, J., Jones, R.H. and Okuda, Y., Oral insulin in diabetic dogs. J. Endocrinol., 131 (1991) 267-278.
19. Saffran, M., Kumar, G.S., Neckers D.G. et al., New approaches to the oral administration of peptide drugs. Pharm. Weekbl. Sci. Ed., 10 (1988) 159-176.
20. Samyn, C., Kalala, W., Van den Mooter, G. and Kinget, R., Synthesis and in vitro biodegradation of poly(ether-ester) azopolymers designed for colon targeting. Int. J. Pharm., 121 (1995) 211-216.
21. Touitou, E. and Rubinstein, A., Targeted enteral delivery of insulin to rats. Int. J. Pharm., 30 (1986) 95-99.
22. Van den Mooter, G., Samyn, C. and Kinget, R., Azo polymers for colon-specific drug delivery. Int. J. Pharm., 87 (1992) 37-46.
23. Van den Mooter, G., Samyn, C. and Kinget, R., Azo polymers for colon-specific drug delivery. Part II: Influence of the type of azo polymer on the degradation by the intestinal microflora. Int. J. Pharm., 97 (1993) 133-139.